Introduction 52
Antimicrobial resistance is a global health problem of particular importance, 53 which has led to an urgent need for new antimicrobial drug development. An 54 alternative approach to this problem is to re-sensitize resistant bacteria to 55 existing antibiotics using novel inhibitors or synergistic combinations of 56 existing drugs that overcome the mechanism(s) of resistance (1). The 57 classical example of this is the combination of β-lactamase inhibitors such as 58 clavulanic acid or sulbactams and a β-lactam antibiotic. Following the 59 introduction of each generation of β-lactam, resistance has rapidly emerged. 60
In the case of Staphylococcus aureus, penicillin resistance mediated by a 61 blaZ encoded β-lactamase (penicillinase) was followed by the emergence of 62 methicillin-resistant S. aureus (MRSA) shortly after the introduction of 63 methicillin (a β-lactamase-resistant β-lactam) in 1961 (2, 3). 64 65 Resistance to β-lactam antibiotics in MRSA is primarily mediated by the 66 acquisition of an alternative penicillin-binding protein 2 (PBP2a) encoded by 67 the mecA gene, which is carried on a mobile element known as a 68 staphylococcal cassette chromosome (SCCmec) (4). In 2011, a new type of 69 MRSA with a divergent mecA homologue known as mecC was described, 70 which like some other types of MRSA is associated with livestock (5, 6). It has 71 been demonstrated that mecC mediates resistance to cefoxitin and oxacillin in 72 a range of strain backgrounds and that mecC expression is inducible with 73 oxacillin (7). The mecC encoded PBP2a (PBP2c) shares only 63% amino acid 74 identity with the mecA encoded PBP2a (PBP2a). The difference in amino acid 75 identity is reflected in the distinct biochemical properties of PBP2c whereby it 76 3 shows a greater affinity for oxacillin than for cefoxitin and is less stable at 77 37°C (8). Furthermore, unlike PBP2a, PBP2c does not require the 78 transglycosylase (TGase) activity of the native PBP2 for high level resistance, 79
suggesting it may preferentially cooperate with an as yet unidentified 80 monofunctional TGase (8) . 81
82
Here we report that the biological differences between PBP2a and PBP2c 83 extend to the unexpected finding that PBP2c does not mediate resistance to 84 penicillin, and that expression of the β-lactamase -blaZ (blaZ LGA251 ) located 85 adjacent to mecC on the SCCmec type XI element is required for broad-86 spectrum resistance to β-lactams. We demonstrate that this singular property 87 of PBP2c can be exploited therapeutically for the treatment of mecC-MRSA 88 infections. 
Materials and methods 102

Media and culture conditions 103
Bacterial strains and plasmids used in this study are described in Table S5 . 104
For routine culture, Escherichia coli was grown in Lysogeny broth (LB) or on 105 L-agar (Oxoid, UK) at 37°C. S. aureus was grown on tryptone soy agar (TSA), 106
Columbia blood agar or in tryptone soy broth (TSB) 
Wax moth larvae (Galleria mellonella) infection and treatment assay 167
The wax moth larvae assay was based on that previously described by 168
Desbois et al (12). Galleria mellonella larvae were purchased in bulk from a 169 commercial supplier: Livefood Ltd, UK. Larvae were stored at 4°C upon arrival 170 and kept at 37°C during the course of the assay. mecC-MRSA strains 171
LGA251, 02.5099.D and 71277 were selected for evaluation of antimicrobial 172 activities of penicillin and clavulanic acid in combination. Single bacterial 173 colonies were picked to inoculate 5 ml of TSB, and cultures were grown 174 overnight (~16 hours) at 37°C and 200 rpm. Cultures were then diluted 1:100 175 into 5 ml of fresh TSB and grown for a further 4 hours at 37°C and 200 rpm. 176
Cultures were then centrifuged at 2,500g for 10 minutes, and pellets 177 resuspended in sterile phosphate buffered saline (PBS) to an OD 595 of 0.2, 178 giving approximately 1.3 × 10 6 CFU (range: 1.1 -1.4 x 10 6 ) in 10 µl . For each 179 strain, six groups of G. mellonella (n=10 in each group) were injected with 10 180 µl aliquots of resuspended culture between two posterior thoracic segments 181 using a Tridak Stepper Pipette Dispenser (Dymax, UK). Groups of G. 182 mellonella were treated by injection with 50 mg/kg vancomycin, 40 mg/kg 183 cefoxitin, 20 mg/kg penicillin sodium salt, 20 mg/kg potassium clavulanate, 20 184 mg/kg penicillin sodium salt combined with 20 mg/kg potassium clavulanate or 185 PBS at 2, 24 and 48 hours after inoculation. The treatments were given blind 186 and the treatment identities not revealed until the experiment was completed. 187
Larvae were considered dead when they did not respond to touch to the head. 188
The experiment was performed twice with almost identical results, results of 189 one experiment are presented in the text ( Once growth occurred at the 4 µg/ml concentration of penicillin, the increment 204 was changed from 2 fold increases to 2 µg /ml increases. At selected time 205 points, cultures were plated out and 2 -3 resistant colonies were picked, 206 penicillin and cefoxitin MIC determined and the mecC gene amplified by PCR 207 using primers mecCf:, mecCm and mecCr and sequenced (Source 208
Bioscience Sequencing, Cambridge, UK) (Table S5) suggesting that PBP2c has a higher affinity for penicillins than cephalosporins 231 restored resistance as previously reported ( Fig. 2A and Table S1) (7). 252
However, deletion of mecC caused no reduction in penicillin resistance in 253 either LGA251 or 02.5099.D, demonstrating that mecC did not mediate 254 resistance to penicillin in either strain background ( Fig. 2B and Table S1 ). In 255 contrast when the blaZ LGA251 gene was deleted, resistance to penicillin was 256 abolished in both strain backgrounds and the penicillin MIC decreased from 8 257 to <0.0075 and 32 to 0.0625 µg/ml in LGA251 and 02.5099.D, respectively 258 ( Fig. 2B and Table S1 ). Complementation of the mutants with blaZ restored 259 penicillin MICs to wildtype levels in both backgrounds ( Fig. 2B and Table S1 ). 260
These findings were confirmed by the creation of double mecC/blaZ deletion 261 strains (LGA251∆mecC∆blaZ) and (02.5099.D∆mecC∆blaZ), which were then 262 individually complemented with plasmid-borne copies of mecC and blaZ. In 263 each case it was the complementation with blaZ and not the complementation 264
with mecC that restored resistance to penicillin ( Fig. 2B and Table S1 ). As penicillin resistance in mecC-MRSA strains is mediated by the blaZ LGA251 269 alone, we tested if mecC-MRSA strains were susceptible to the combination 270 of penicillin and clavulanic acid (a β-lactamase inhibitor). We included 271 clavulanic acid at a clinically relevant concentration of 15 µg/ml in 272 bacteriological media and carried out penicillin and cefoxitin disc diffusion 273 assays according to BSAC criteria, against a panel of 30 mecC-MRSA 274 isolates ( Fig. 3) (19, 20) . This showed that clavulanic acid increased 275 susceptibility to penicillin in all strains tested (except strain Sa09315 which 276 was already susceptible due to a frameshift in blaZ) and more than doubled 277 the mean zone of inhibition (10 cf. 27 mm -resistance cut off = 24 mm) ( Fig.  278 3). Furthermore, clavulanic acid reduced the penicillin MICs by a mean of 65-279 fold and restored breakpoint susceptibility in 24 of 30 strains tested (Fig. 3A) . 280
In the remaining 6, the MIC was reduced to the breakpoint (breakpoint 0.12 281 µg/ml) (Fig. 3A) . In contrast, only minor reductions were seen for cefoxitin 282 when combined with clavulanic acid (Fig. 3B ). In view of the relative instability 283 of PBP2c at higher temperatures (the assays were performed at 35ºC), we 284 confirmed the effect of clavulanic acid on cefoxitin and penicillin at 25, 30 and 285 37ºC. The results for cefoxitin showed a clear increase in the zone of 286 inhibition with increasing temperature, as previously reported, with no major 287 effect of clavulanic acid seen at any temperature (8) (Fig. S1 ). While for 288 penicillin there was only a minor effect with increasing temperature and similar 289 zones of inhibition in the presence and absence of clavulanic acid (Fig. S1) . results showed that clavulanic acid increased susceptibility to all penicillins 299 tested except for oxacillin ( Fig. 3C and Table S2 ). Oxacillin was tested on 300
Mueller-Hinton agar as recommended by BSAC, EUCAST and CLSI 301 guidelines, and also using Iso-Sensitest where there was a small decrease in 302 the presence of clavulanic acid (mean 20 cf. 24 mm), which was less than that 303 observed for other penicillins. The effect of clavulanic acid was most 304 pronounced for penicillin (mean 11 cf. 27 mm), amoxicillin (mean 22 cf. 34 305 mm), ampicillin (mean 24 cf. 36 mm), and temocillin (mean 7 cf. 17 mm) ( Fig.  306 3 and Table S2 ). Only very small increases in susceptibility were seen in the 307 presence of clavulanic acid for the tested cephalosporins and carbapenems, 308 and no effect at all was seen for the one monobactam tested (aztreonam) 309 ( Fig. 3 and Table S2 ). 310
311
To further understand the basis for the effect of clavulanic acid, we next 312 tested the mecC/blaZ deletion mutant strains against the same range of β-313 lactams in disc diffusions assays, alone and in the presence of 15 µg/ml 314 clavulanic acid (Table S1 ). The results showed that the effect of clavulanic 315 acid on penicillin resistance was negated in both the LGA251ΔblaZ and 316 02.5099.DΔblaZ, indicating that, as would be expected, the zone increases 317 mediated by clavulanic acid were dependent on the blaZ LGA251 encoded β-318 lactamase (Table S1 ). Interestingly, the presence of clavulanic acid alone in 319 the media prevented growth of both the ∆mecC strains. Furthermore 320 complementation with mecC on a plasmid failed to reverse this, nor was this 321 effect seen in either of the ∆blaZ strains (LGA251∆blaZ and 02.5099.DΔblaZ) 322 demonstrating that it was not a by-product of the mutant construction process 323 per se but most likely due to the specific loss of the chromosomally encoded 324 mecC (Table S1) . 325 326
Selection of penicillin resistance in mecC-MRSA isolates 327
Next we sought to elucidate the molecular basis for why PBP2c was unable to 328 mediate resistance to penicillin. We first attempted to identify mecC mutations 329 that conferred resistance to penicillin by screening a collection of whole 330 genome sequenced mecC-MRSA isolates (data not shown) to identify 331 naturally occurring amino acid substitutions. We identified ten different amino 332 acid substitutions present in PBP2c and tested representative isolates by 333 penicillin disc diffusion with clavulanic acid to see if there was any effect on 334 penicillin susceptibility (Table 1) . None of the isolates tested showed any 335 resistance to the combination of penicillin and clavulanic acid. We next sought 336 to select mutants in vitro with PBP2c mutations conferring penicillin 337 resistance. We grew two wildtype mecC-MRSA strains: LGA251 and 338 02.5099.D in gradually increasing concentrations of penicillin supplemented 339 with clavulanic acid at 15 µg/ml for forty days (Fig. 4) . We also grew the 340 corresponding isogenic ∆blaZ mutants (LGA251ΔblaZ and 02.5099.DΔblaZ) 341 in penicillin alone (Fig. 4) . At a number of points in the experiment, isolates 342 were plated to single colonies and 2-3 individual colonies tested for penicillin 343 and cefoxitin MIC and mecC sequenced to identify potential mutations 344 mediating penicillin resistance (Fig. 4) . The MIC testing of LGA251ΔblaZ from 345 day 9 and 02.5099.DΔblaZ from day 13 showed that as well as becoming 346 penicillin resistant the strains had also substantially increased their resistance 347 to cefoxitin (8 cf. ≥ 128 µg/ml), suggesting the change seen was a general 348 increase in β-lactam resistance and not specific to penicillin (Table S3) (Table S4 ). We cloned the mutated mecC gene (mecC Val546Ile ) from 02.5099-360 D40-A-C1 and 02.5099-D40-A-C2 into RN4220 and into blaZ-mecC-null 361 strains LGA251ΔblaZΔmecC and 02.5099.DΔblaZΔmecC and tested 362 resistance to penicillin and cefoxitin using disc diffusion. We found that the 363 strains with mecC Val546IIe were equally susceptible to penicillin as the wildtype 364 mecC, demonstrating that the Val546Ile substitution alone was not capable of 365 mediating resistance ( Fig. S2A and Table S4 ). Interestingly however, when 366 we tested the mecC Val546Ile strains for cefoxitin resistance, we found that the 367 strains were not resistant to cefoxitin as measured by disc diffusion and had 368 an MIC of 2 µg/ml in comparison to 16 µg/ml for strains expressing wildtype 369 mecC ( Fig. S2B and Table S4 ). Further disc diffusion testing against the full 370 panel of ß-lactams, revealed that the Val546Ile substitution only effected 371 resistance to cefoxitin (Table S4 ). This demonstrates the importance of valine 372 at position 546 for specifically mediating cefoxitin resistance in PBP2c. MRSA strains belonging to different multi-locus sequence types;
LGA251 381 (ST425), 02.5099.D (ST1944), 71277 (ST130) (12). We compared the effect 382 of penicillin / clavulanic acid (2:1) with penicillin, clavulanic acid, cefoxitin and 383 PBS against a gold standard treatment of vancomycin (Fig. 5 ). For both 384
LGA251 and 02.5099.D 10% of larvae treated with PBS or clavulanic acid 385 survived to 120 hours, while for 71277, larvae were all dead by 48 and 68 386 hours, respectively (Fig. 5) . Treatment with penicillin alone led to a modest 387 improvement, with survival at 120 hours of 20% for LGA251, 30% in 388 02.5099.D and 20% in 71277 ( Fig. 5 ). Despite the presence of PBP2c, 389 cefoxitin performed moderately better than penicillin and with survival at 120 390 hours to 40% in LGA251 and 71277 and to 50% in 02.5099.D. In contrast, 391 survival at 120 hours for penicillin and clavulanic acid was 90% for LGA251, 392 65% for 71277 and 70% for 02.5099.D (Fig. 5 ). While the 'gold standard' 393 treatment of vancomycin had survival at 120 hours of 90% for LGA251 and 394 80% for, 02.5099.D and 71277, respectively (Fig. 5 ). Statistical analysis 395 showed there was no significant difference between treatment with a 396 combination of penicillin and clavulanic acid and vancomycin (Log-rank 397 (Mantel-Cox) Test: LGA251; P = 0.970, 02.5099.D; P = 0.259, and 71277; P = 398 0.370). Repeat experiments showed broadly identical results (Fig. S3) . 399 400
Discussion 401
Antibiotic resistance is major international problem and with few new 402 antibiotics likely to be available in the immediate future. Novel methods to 403 combat antibiotic resistance are therefore required, including repurposing 404 older antibiotics. Here, we present evidence of one such case. We show that, 405 the newly described mecC encoded PBP2c does not mediate resistance to 406 penicillin and that the adjacently encoded type E blaZ gene is required for 407 resistance to penicillin. Our data suggest that this biological difference can be 408 exploited for treatment by combining penicillin and clavulanic acid, a β-lactam 409 inhibitor, to block the action of the blaZ LGA251 -encoded β-lactamase. 410
Importantly, we show that our in vitro data translate to successful treatment of 411 experimental infections in vivo in a non-vertebrate model. The combination of 412 penicillin and clavulanic acid was as effective as vancomycin in reducing the 413 mortality of wax moth larvae infected with three different mecC-MRSA strains. 414
We also observe in vitro activity of clavulanic acid in combination with 415 amoxicillin -a combination that is already commercially available as 416
Augmentin -suggesting that drugs already in clinical use might be successful 417 in treating mecC-MRSA infections. Additionally, variable resistance to different 418 cephalosporins has been reported previously for mecC-MRSA isolates, 419
suggesting that certain cephalosporins might also be also be used for 420 treatment (21). Our data for thirty mecC-MRSA isolates found uniform zones 421 of inhibition ( Fig. 3C ) for all the cephalosporins tested, including susceptibility 422 to ceftaroline (the new anti-MRSA cephalosporin). However given the reliance 423 of cefoxitin/oxacillin testing for MRSA detection there is a lack of clinical 424 breakpoints for most cephalosporins, therefore it is not clear if these zones of 425 inhibition would translate into clinical efficacy, further work is required to 426 address this question. 427 428 These findings suggest that penicillin can readily bind to PBP2c to prevent cell 429 wall biosynthesis, a notion supported by data from Kim et al., which showed a 430 higher binding affinity between the PBP2c to penicillins than cephalosporins in 431 comparison to PBP2a (8) . This is consistent with our finding that clavulanic 432 acid was effective at conferring increased susceptibility against all the tested 433 penicillins (except oxacillin) but had no effect against cephalosporins, It 434 remains to be seen if this property is conserved amongst the variants of mecC 435 identified in different coagulase negative staphylococci (15, (22) (23) (24) . 436
437
Biologically, the finding that the PBP2c has evolved so as not to mediate 438 resistance to penicillin is of interest. The linkage of both mecC and blaZ LGA251 439 on a single genetic element might have enabled PBP2c to evolve distinct 440 properties from PBP2a, without the constraint of having to mediate resistance 441 to penicillin. This might suggest that the selective pressure to mediate 442 resistance to cephalosporins or as yet unidentified β-lactam(s) under specific 443 conditions (temperature, pH, ion concentration, etc) has selected PBP2c to be 444 unable to mediate resistance to penicillin. Indeed, the previous demonstration 445 that PBP2c is unstable at 37º, suggests that selection pressures might have 446 selected for function at lower temperatures (8). Equally, it is known that there 447 are specific fitness costs associated with expression of PBP2a including a loss 448 of toxicity and later biofilm formation, and that high level ß-lactam resistance 449 requires epistatic mutations (25-28). It remains to be seen what the distinct 450 advantage of the PBP2c is in comparison to PBP2a or the selective pressures 451 that have driven this. 452 453 mecC-MRSA strains are commonly isolated from cattle (29), and it is possible 454 that the routine use of both 1 st and 3 rd generation cephalosporins for the 455 treatment and prevention of mastitis may have provided the selective 456 pressure that has driven the emergence of mecC-MRSA in dairy cows (30) . 457
Future studies should be targeted to investigate this question to provide 458 insight for improvements in antibiotic stewardship in veterinary medicine. 459
We have also identified the first mutation associated with specific loss of 460 cefoxitin resistance in PBP2c. Comparison of PBP2c and PBP2a structures 461 suggests this substitution might effect lobe:lobe positioning; also, V546 is 462 adjacent to a beta strand "cascade" that likely packs differently in 463 
